Skip to search formSkip to main contentSkip to account menu

Tegafur

Known as: 1-(Tetrahydro-2-furanyl)-5-fluorouracil, Tegafur [Chemical/Ingredient], 5-Fluoro-1-(tetrahydro-2-furanyl)-2,4-pyrimidinedione 
A congener of the antimetabolite fluorouracil with antineoplastic activity. Tegafur is a prodrug that is gradually converted to fluorouracil in the… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1995
1995
In order to find out whether the response rate and survival in epithelial ovarian cancer can be improved by aid of sensitivity… 
1985
1985
5'-Deoxy-5-fluorouridine (5'-DFUR) was evaluated for antitumor activity against four murine tumors (L1210 leukemia, P388 leukemia… 
1985
1985
We have studied the pharmacology of iv and oral tegafur (FT) and compared the results with similar studies using continuously… 
1983
1983
A phase I clinical study of tegafur (ftorafur) was conducted in 29 patients with various advanced solid tumors. To evaluate its… 
1983
1983
The possible use of poly (ethylene carbonate) and poly (propylene carbonate) pellets for sustained release of 5-fluorouracil… 
Review
1982
Review
1982
To examine FT-207 cardiotoxicity, medical records of 223 cancer patients from 23 institutions throughout Japan were subjected to… 
1978
1978
A photosensitive lichen planus-like eruption developed in a 63-year-old man during postoperative chemotherapy with 1-(2… 
1978
1978
Antitumor activity of 1-hexylcarbamoyl-5-fluorouracil (HCFU) against Lewis lung carcinoma and B16 melanoma by long-term oral… 
1976
1976
Antitumor activity of 1-hexylcarbamoyl-5-fluorouracil against various tumors was examined. Therapeutic ratio (ILSmax/ILS30) in L…